Results     23-May-23
Announcements
Indoco Remedies standalone net profit declines 37.16% in the March 2023 quarter
Sales rise 6.94% to Rs 428.05 crore
Net profit of Indoco Remedies declined 37.16% to Rs 25.37 crore in the quarter ended March 2023 as against Rs 40.37 crore during the previous quarter ended March 2022. Sales rose 6.94% to Rs 428.05 crore in the quarter ended March 2023 as against Rs 400.27 crore during the previous quarter ended March 2022.

For the full year,net profit declined 8.52% to Rs 141.36 crore in the year ended March 2023 as against Rs 154.52 crore during the previous year ended March 2022. Sales rose 9.01% to Rs 1638.13 crore in the year ended March 2023 as against Rs 1502.70 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales428.05400.27 7 1638.131502.70 9
OPM %14.9920.10 -17.3921.76 -
PBDT56.0277.72 -28 262.19315.18 -17
PBT38.3359.68 -36 191.59236.23 -19
NP25.3740.37 -37 141.36154.52 -9

Previous News
  Indoco Remedies consolidated net profit declines 29.46% in the September 2023 quarter
 ( Results - Announcements 19-Oct-23   14:00 )
  Indoco Remedies Q2 PAT slides 33% YoY to Rs 33 cr
 ( Hot Pursuit - 19-Oct-23   15:12 )
  Indoco Remedies receives USFDA approval for Cetirizine Hydrochloride Tablets
 ( Corporate News - 04-Oct-24   14:26 )
  Warren Remedies commences commercial production of its greenfield units at Aurangabad
 ( Corporate News - 26-Mar-24   09:34 )
  Indoco Remedies to table results
 ( Corporate News - 11-Jan-24   11:27 )
  Indoco Remedies' APIL Kilo Lab manufacturing unit completes USFDA audit
 ( Corporate News - 17-May-24   10:43 )
  Sensex down 224 pts; media shares decline
 ( Market Commentary - Mid-Session 09-Jun-23   14:32 )
  Indoco Remedies standalone net profit rises 19.41% in the September 2022 quarter
 ( Results - Announcements 10-Nov-22   12:17 )
  Indoco Remedies consolidated net profit rises 19.29% in the September 2022 quarter
 ( Results - Announcements 10-Nov-22   12:18 )
  Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg
 ( Corporate News - 21-Aug-24   19:58 )
  Volumes spurt at Gujarat State Fertilizers & Chemicals Ltd counter
 ( Hot Pursuit - 22-Jul-22   11:00 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top